Davipharm

Mr. Wojciech Makowski , Operations Director of Davipharm, captures the spirit of the company with his assertion that “Sky is the limit.” This mindset reflects the company’s ambitions and strategic development plans. For over 20 years, Davipharm has demonstrated its resilience, navigating obstacles to emerge as a leading player in Vietnam’s pharmaceutical industry.

As a member of Adamed Group, Davipharm stands out as one of the top manufacturers of high-quality domestic drugs. The company reached a significant milestone in 2021 by obtaining its first EU-GMP certification, a testament to its commitment to maintaining international manufacturing standards. This achievement placed Davipharm among an elite group of Vietnamese pharmaceutical companies recognized for their adherence to rigorous quality protocols.

With a product range covering 12 therapeutic areas, Davipharm responds to the key challenges of modern medicine by delivering high quality products and services at affordable prices, elevating the image of made in Vietnam medicines and supplying products to local and international markets.

Since 2019, Vietnam has hosted the ADAMED SmartUP program, marking the first expansion of this flagship initiative outside Poland. In collaboration with the Polish Embassy in Hanoi, the program supports students interested in science. The initiative offers English courses, environmental workshops, and educational equipment to students at the Vietnam-Poland Friendship High School. By the end of the 2023-2024 academic year, 750 students participated, with nine winners attending a scientific summer camp in Poland.

On June 25, 2020, Davipharm celebrated its first Adamed International Values Day. This annual event underscores the company’s integration into the Adamed Group’s international community, reflecting shared corporate values – Openness and Innovation, Quality, Mutual Respect, Operational Excellence Flexibility and Speed of Action. The alignment of local and European values highlights the universal commitment to fostering a supportive and dynamic workplace culture.

Photo: Davipharm’s first Adamed International Values Day on June 25, 2020.

Davipharm actively collaborates with numerous educational institutions, including the University of Medicine and Pharmacy in HCMC, Binh Duong Medical College, Vietnamese-German University, Vietnam National University HCMC, and Van Lang University. These partnerships facilitate academic activities, factory tours, internships, scholarships, and trainee programs, providing valuable opportunities for students and future professionals.

Despite the challenges posed by the COVID-19 pandemic, Davipharm achieved impressive growth in 2022, driven by successful national tenders. This performance led to a historic production output of 670 million tablets in 2023, showcasing the company’s resilience and operational excellence.

Photo: Davipharm’s storage capacity will have to expand to support ambitious production plans.

Mrs. Małgorzata Adamkiewicz, President of the Supervisory Board of Adamed Pharma, emphasizes the importance of employee satisfaction for business success. Her remarks were validated by Adamed Pharma’s ranking as the top employer in the pharmaceutical and biotechnology industry in Poland’s Forbes Polska Ranking for 2023 and 2024. The company’s commitment to employee well-being has also been recognized in Vietnam, with Davipharm nominated for the Top 100 Best Places to Work in Vietnam by Anphabe in 2024.

Davipharm employs over 450 people across its Binh Duong factory and Ho Chi Minh City office. The company prides itself on its diverse team of experts from various countries. This multicultural environment enriches the company culture and bolsters its ability to attract, recruit, and retain top talent. Davipharm’s Future Leader Program 2023-2026 is a key initiative designed to develop competencies within its team, fostering skills in multicultural cooperation and leadership.

Photo: A training trip for the Davipharm talent team to Poland in 2024.

Ranked as the seventh-largest local pharmaceutical company in Vietnam’s prescription drug market according to IQVIA data for Q1-2024, Davipharm is set on expanding its international presence. The company plans significant investments in infrastructure to enhance production and storage capacities. Projects include increasing production capacity to 1.5 billion tablets and constructing additional facilities in Binh Duong to support the delivery of up to 2 billion units annually.

Mr. Michal Wieczorek , General Director of Davipharm,underscores the exceptional talent pool in Vietnam and its potential for global competitiveness. Davipharm’s strategic goals extend beyond production and sales, focusing on workforce development and continuous training. Investing in employees is seen as crucial for sustained success, ensuring that the team remains innovative and competitive in the global market.

As Davipharm continues to evolve and expand, its commitment to quality, talent development, and community impact remains central to its success. The company’s journey is a testament to its dedication to excellence and its vision of becoming a leading pharmaceutical manufacturer both locally and internationally.

Check out the article on Vietnam.vn HERE!